Special issue “Cyclodextrin-Based Drug Delivery System”
Pharmaceutics, a peer-reviewed open access journal (Impact Factor: 4.77) on the science and technology of pharmaceutics and biopharmaceutics, published monthly
Category: Drug delivery
Gilead to expand access to remdesivir, its promising coronavirus treatment
Gilead Sciences Inc. will expand access to its experimental anti-coronavirus drug SBECD-enabled remdesivir to accelerate its emergency use for multiple
Chloroquine against Covid-19?
The antimalarial drug, chloroquine has been claimed effective in the treatment of patients infected by the novel emerged coronavirus, Covid-19
Ginkgo terpenoid against COVID-19
Due to the reported high ability of virulence of COVID_19 in recent months, several studies have been conducted to discover
International Conference on Nanomedicine and Drug Delivery Systems
ICND 2020 is going to be held during April 15-17, 2020 in Radisson Narita, Tokyo, Japa in collaboration with European
Postponed to August 5-7: 10th Annual Congress of Nano Science and Technology-2020 (Nano S&T-2020)
The Novel Coronavirus (COVID-19) has infected more than 60,000 people in over two dozen countries. Considering its global influence, travel
Postponed to 2021: 12th World Meeting on Pharmaceutics, Biopharmaceutics & Pharmaceutical Technology
Due to the spreading of the corona-virus the 12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology (which was initially
Prof. Uekama awarded
Prof. Kaneto Uekama (Professor Emeritus of Kumamoto Uuniversity, Advisor of the Society of Cyclodextrins, Japan) was awarded the Order of
Nasal delivery with beta-cyclodextrin is approved; a short story of Baqsimi
Cyclodextrins have not been popular excipients for nasal or pulmonary drug delivery so far. This can change soon, with the
4th Global Summit on Nanotechnology
Following our successful 3rd World Congress and Expo on Nanotechnology and Materials Science in Dubai, UAE on 25-27 June 2018,